Compounding partners

Any preparation that is legal to compound in the United States. Our 503B facilities make the sterile injectables: vials, prefilled syringes, premixed bags and pellets. Our 503A pharmacies make the tablets, capsules, chews, troches, creams and drops. Everything ships only to licensed prescribers, clinics, pharmacies and medical groups. We negotiate the contract, help you reformulate, and keep the supply running, with some of the largest facilities in the United States.

503APatient-specific pharmacies
503BFDA-registered outsourcing facilities
2Facilities per core product
$0Markup on the facility's price

Your supply agreement

503B outsourcing facility · office stock

Signed
  • Testosterone cypionate 200 mg/mL10 mL vials · cGMP lot with CoA
  • NAD+ 100 mg/mL5 mL vials · cold chain
  • Lidocaine / tetracaine numbing cream30 g jars · case minimum 12
  • Net-30 terms, price locked 90 days

Patient prescription

503A pharmacy · shipped to the patient

Send to pharmacy
  • Estradiol / progesterone cream
  • Low-dose naltrexone 4.5 mg
  • Tretinoin 0.05% / niacinamide 4%
  • Refill in 28 days
One partner for both sides of the counter.
503A

A 503A pharmacy is a traditional compounding pharmacy. The name comes from Section 503A of the Federal Food, Drug, and Cosmetic Act, which sets the conditions under which a licensed pharmacist (or a physician) can prepare a medication for one specific patient without that preparation going through FDA approval.

The defining rule is the prescription. A 503A pharmacy compounds a preparation only after it receives a valid prescription for a named patient, or in limited quantities in anticipation of prescriptions it regularly fills. It cannot keep stock on hand to sell to clinics for in-office use, even in states whose own laws allow it, because federal law does not provide for office-use supply under 503A.

Oversight sits mainly with the state board of pharmacy, with FDA stepping in for specific federal provisions. Quality is governed by the United States Pharmacopeia chapters on non-sterile compounding (<795>), sterile compounding (<797>) and hazardous drugs (<800>). Ingredients must meet a USP or NF monograph, be a component of an FDA-approved drug, or appear on FDA's 503A bulk-substances list.

A 503A pharmacy may not compound a preparation that is essentially a copy of a commercially available FDA-approved drug, unless the prescriber documents a change that makes a significant clinical difference for that patient, such as a different strength, an allergen removed, or a different dosage form. It also cannot compound drugs FDA has withdrawn for safety reasons, and its ability to ship across state lines is limited under FDA's memorandum-of-understanding rules.

  • A valid prescription for a named patient, every time
  • Regulated mainly by the state board of pharmacy
  • USP <795>, <797> and <800> standards
  • Custom strengths, dosage forms, flavors, and allergen-free or preservative-free versions
  • Best for hormone therapy, dermatology, pediatrics, veterinary care, hospice and anything that needs personalizing
503B

A 503B outsourcing facility is a compounder that has registered with FDA under Section 503B of the Federal Food, Drug, and Cosmetic Act. Congress created the category in the Drug Quality and Security Act of 2013, after a 2012 outbreak of fungal meningitis traced to contaminated sterile injections from a compounding pharmacy.

The defining feature is scale without a prescription. A 503B facility can compound in large batches and sell to hospitals, surgery centers, clinics, med spas and physician offices for office use, with no patient named in advance. It can also fill patient-specific prescriptions. In return it is held to a manufacturer-style standard: current good manufacturing practice (cGMP), FDA inspections, annual registration and fees, product reports to FDA twice a year, and adverse-event reporting.

Every lot is compounded by or under the direct supervision of a licensed pharmacist, released with testing (potency, sterility and endotoxin for injectables), and labeled with the facility's name, the lot number, a beyond-use date and the words “This is a compounded drug.” Bulk ingredients can only be used if they appear on FDA's 503B bulk-substances list or the drug is on FDA's shortage list, and the facility cannot compound a product that is essentially a copy of an approved drug unless that drug is in shortage.

The result is a reliable, inspected supply of ready-to-use vials, prefilled syringes, premixed bags, creams and kits that a practice can keep on the shelf, at a per-unit cost that drops with volume.

  • Registered with FDA and inspected to cGMP
  • Sells office stock to licensed practices and hospitals with no patient-specific prescription
  • Tested, lot-numbered products with a certificate of analysis
  • Large batches, multi-state distribution and standing orders
  • Best for injectables, prefilled syringes, premixed IVs, numbing creams and any product you use on site every day
Side by side

503A compounding pharmacy503B outsourcing facility
Prescription requiredYes, for a named patientNo, office stock is allowed
Who oversees itState board of pharmacy, with specific federal provisionsFDA registration and inspections, plus state licensing
Quality standardUSP <795>, <797>, <800>Current good manufacturing practice (cGMP)
Sells to clinics for in-office use—
Ships to patients directlyThrough a prescription, where licensed
Ships across state linesLimitedYes, to licensed sites in states where it holds a license
Batch sizeOne prescription at a time, plus limited anticipatory batchesLarge validated batches
Lot testing and certificate of analysisPer state rules, often not required
Custom formulation per patientStandardized products only
Price per unitHigherLower, falls with volume
Minimum orderNoneOften a case minimum per product
Typical lead time1–5 days per prescriptionStocked items ship in days; new products take weeks
Best forPersonalized therapy and patient shippingEverything you use on site, in volume
By dosage form

If it is legal to compound in the United States, one of our partners makes it, and it ships only to licensed accounts.

Vials and multi-dose injectablesSterile, lot-tested, office stock. 503B.
Prefilled syringesReady to administer. 503B.
Premixed IV bagsInfusion-ready. 503B.
PelletsFor in-office insertion. 503B.
Tablets and capsulesCustom strengths. 503A.
Chews and trochesFlavored, patient-specific. 503A.
Creams, gels and foamsTopical and transdermal. 503A.
Suspensions and dropsOral, ophthalmic, nasal. 503A.
Formulary

From our partner formularies: the same compounded programs the national telehealth brands run, in weight management, hormones, testosterone, hair, skin and sexual health, plus the specialty work clinics and hospitals need. If it is on this list, we have a licensed facility under contract that makes it.

Partner formulary · examples

CategoryExample preparations503A503B
Hormone therapyEstradiol, estriol (Biest), progesterone, testosterone, DHEA, pregnenolone in creams, capsules, troches and pelletsYesPellets, vials
Men's health and TRTTestosterone cypionate and enanthate vials, gonadorelin, anastrozole and clomiphene low-dose capsulesPer patientOffice stock
Weight managementSemaglutide and tirzepatide vials and troches, lipotropic (MIC) and B12 injections, low-dose naltrexoneYesOffice stock
IV and injectable nutrientsVitamin C, B-complex, B12, magnesium, zinc, glutathione, amino-acid blends, Myers'-style componentsPer patientOffice stock
LongevityNAD+ injections and nasal sprays, methylene blue, glutathione, low-dose sirolimus capsulesYesVials
Women's healthVaginal estriol and DHEA, testosterone cream for women, progesterone for perimenopause, oxytocin, custom libido preparationsYesRare
Sexual healthSildenafil and tadalafil troches and ODTs, Trimix / Bimix / Quadmix injections, oxytocin, vaginal DHEA and estriolYesTrimix vials
DermatologyTretinoin combinations, hydroquinone blends for melasma, azelaic acid, topical spironolactone, oral and topical tranexamic acidYesSelect creams
AestheticsLidocaine / tetracaine (BLT) numbing creams, buffered lidocaine with epinephrine, hyaluronidase, tranexamic acid injectionsPer patientOffice stock
Hair restorationTopical minoxidil with finasteride or dutasteride, low-dose oral minoxidil, latanoprost and ketoconazole topicalsYesRare
Pain managementKetamine, gabapentin, lidocaine, diclofenac and baclofen topical blends, ketamine troches, ketorolac and trigger-point injectionsYesSyringes, vials
Ketamine and infusion clinicsKetamine vials and prefilled syringes, ondansetron, midazolam, premixed infusion bagsPer patientOffice stock
OphthalmologyAtropine 0.01% for myopia, autologous serum tears, fortified antibiotics, repackaged bevacizumab syringes, intracameral moxifloxacin, dilating combinationsDropsSyringes, drops
Hospital and surgery centerPrefilled syringes (phenylephrine, ephedrine, succinylcholine, rocuronium, opioids), premixed norepinephrine and oxytocin bags, epidural mixes, cardioplegia, pediatric dilutionsRareCore business
PediatricsFlavored suspensions, dye-free and allergen-free versions, dose conversions of tablets into liquids, propranolol and omeprazole suspensionsYesDilutions
DentalProfound-style topical anesthetics, triple antibiotic paste, dry-socket paste, chlorhexidine and fluoride preparationsYesNumbing gels
VeterinarySpecies-specific doses, transdermal methimazole for cats, flavored chews, gabapentin and other suspensionsYesClinic stock
Hospice and palliativeABH gel (lorazepam / diphenhydramine / haloperidol), concentrated oral solutions, suppositoriesYesRare
AllergySublingual allergen drops and custom immunotherapy preparationsYesRare
Thyroid and adrenalSlow-release T3 and T4, T3/T4 combinations, hydrocortisone and melatonin in custom strengthsYesRare
503A in depth

A 503A preparation exists because an approved drug doesn't fit the patient: wrong strength, wrong form, an allergen, a flavor a child won't take, or a combination that saves four separate prescriptions.

503B in depth

A 503B product exists because a practice uses it every day and needs it tested, labeled, shelf-stable and on hand before the patient walks in.

Services

What you can ask for once a contract is in place.

503A compounding pharmacy

  • Custom strength and dose for a single patient
  • Dosage-form changes: capsule to liquid, troche, orally dissolving tablet, cream, gel, suppository, nasal spray or patch
  • Several active ingredients combined into one preparation
  • Flavoring for children and animals
  • Dye-free, gluten-free, lactose-free, preservative-free and sugar-free versions
  • Preparations of drugs that are discontinued, back-ordered or never sold in that form
  • Patient-specific sterile injectables, eye drops and inhalations under USP <797>
  • Hazardous-drug compounding under USP <800>
  • Prescriber consultations on strength, vehicle and compatibility
  • Direct shipping to the patient in states where the pharmacy is licensed
  • Telehealth prescription routing and electronic prescribing
  • Refill reminders, adherence packaging and patient counseling

503B outsourcing facility

  • Office-use stock with no patient-specific prescription
  • Large-batch sterile injectables in multi-dose and single-dose vials
  • Prefilled, labeled syringes ready to administer
  • Premixed IV bags and infusion add-ins
  • Repackaging of approved drugs into ready-to-use units
  • Stability-tested beyond-use dates, often months rather than days
  • A certificate of analysis with every lot: potency, sterility and endotoxin
  • cGMP documentation for your accreditation and audits
  • Cold-chain shipping and temperature logs
  • Standing orders and automatic replenishment
  • Distribution to every licensed site across the states where the facility holds a license
  • Shortage substitutes when an approved drug is on FDA's list
How we get you a contract

    01
    Step 1

    Discovery

    What you prescribe or administer, which states you operate in, your monthly volumes, and whether you need patient shipping, office stock or both.

    02
    Step 2

    Match

    We shortlist facilities that are licensed in your states, already make what you need, and have capacity. Usually one 503B for stock and one 503A for patient prescriptions.

    03
    Step 3

    Reformulation

    We work with the facility's pharmacists on strengths, vehicles and combinations that patients tolerate, that fit your protocols, and that stay inside the copy rules.

    04
    Step 4

    Contract

    Pricing tiers by volume, case minimums, lead times, shipping, returns, a price-lock period, shortage clauses and payment terms. We negotiate all of it and you sign with the facility directly.

    05
    Step 5

    Onboarding

    Account setup, prescriber credentialing, state license and DEA verification, ordering portal access, and routing from your EMR or telehealth platform.

    06
    Ongoing

    Supply watch

    We track FDA's bulk-substance and shortage lists, re-price at each lock period, and keep a second facility ready so one backorder never stops your clinic.

What Nutricove does

Facilities sell to thousands of accounts. We make sure yours gets the pricing, the attention and the paperwork of a large one.

Contract negotiationVolume tiers, minimums, price locks and terms.
ReformulationStrengths, vehicles and combinations that work for your patients and pass the copy rules.
Multi-state licensing checkWhich facility can legally ship to each of your sites and patients.
Telehealth integrationPrescription routing from your platform, built with our Telehealth Launch team.
LogisticsCold chain, delivery windows, returns and backorder handling.
Compliance watchFDA lists, state rules and labeling changes, before they hit your shelf.
Price benchmarkingWhat other practices your size pay, so you don't overpay.
Backup supplyA second facility under contract for your core products.
Who we do this for

FAQ

Tell us what you dispense. We'll tell you which facility, at what price.

A 30-minute supply call covers your states, your products and your volumes, and ends with a shortlist.

Book a supply call→